Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2019

Nov 12, 2019

SELL
$8.15 - $15.88 $169,520 - $330,304
-20,800 Closed
0 $0
Q2 2019

Aug 12, 2019

SELL
$13.2 - $20.39 $619,436 - $956,841
-46,927 Reduced 69.29%
20,800 $281,000
Q1 2019

May 07, 2019

BUY
$15.93 - $26.59 $760,291 - $1.27 Million
47,727 Added 238.64%
67,727 $1.22 Million
Q4 2018

Feb 12, 2019

BUY
$16.25 - $28.09 $325,000 - $561,800
20,000 New
20,000 $561,000

Others Institutions Holding KNSA

About Kiniksa Pharmaceuticals, Ltd.


  • Ticker KNSA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 34,470,400
  • Market Cap $672M
  • Description
  • Kiniksa Pharmaceuticals, Ltd., a biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases with significant unmet medical needs worldwide. Its product candidates include ARCALYST, an interleukin-1alpha and interleukin-1beta, for the treatm...
More about KNSA
Track This Portfolio

Track Spark Investment Management LLC Portfolio

Follow Spark Investment Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Spark Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Spark Investment Management LLC with notifications on news.